Get the Stockscreener App
74.50
0.00%
0.00
After Hours:
74.50
Hologic Inc stock is traded at $74.50, with a volume of 1.67M.
It is up +0.00% in the last 24 hours and down -0.40% over the past month.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.
See More
Previous Close:
$74.50
Open:
$74.5
24h Volume:
1.67M
Relative Volume:
0.51
Market Cap:
$16.62B
Revenue:
$4.04B
Net Income/Loss:
$557.10M
P/E Ratio:
30.91
EPS:
2.4102
Net Cash Flow:
$916.70M
1W Performance:
-0.60%
1M Performance:
-0.40%
6M Performance:
+14.42%
1Y Performance:
+2.45%
1-Day Range:
$74.41
$74.56
1-Week Range:
$74.19
$75.03
52-Week Range:
$51.90
$75.34
Hologic Inc Stock (HOLX) Company Profile
Name
Hologic Inc
Sector
Industry
Phone
(508) 263-2900
Address
250 CAMPUS DRIVE, MARLBOROUGH, MA
Compare HOLX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
HOLX
Hologic Inc
|
74.50 | 16.62B | 4.04B | 557.10M | 916.70M | 2.4102 |
|
ISRG
Intuitive Surgical Inc
|
577.81 | 204.60B | 9.61B | 2.77B | 2.27B | 7.555 |
|
BDX
Becton Dickinson Co
|
196.33 | 55.88B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.38 | 39.38B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
RMD
Resmed Inc
|
244.76 | 35.68B | 5.26B | 1.44B | 1.76B | 9.7713 |
|
MDLN
Medline Inc
|
44.13 | 34.85B | 27.43B | 1.27B | 1.01B | 1.5829 |
Hologic Inc Stock (HOLX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Nov-21-25 | Downgrade | BNP Paribas Exane | Outperform → Neutral |
| Oct-07-25 | Upgrade | Evercore ISI | In-line → Outperform |
| Aug-18-25 | Upgrade | Argus | Hold → Buy |
| Aug-06-25 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-09-25 | Upgrade | Citigroup | Neutral → Buy |
| May-27-25 | Reiterated | Needham | Hold |
| Mar-03-25 | Downgrade | Argus | Buy → Hold |
| Feb-06-25 | Downgrade | Leerink Partners | Outperform → Market Perform |
| Feb-03-25 | Downgrade | Needham | Buy → Hold |
| Dec-13-24 | Initiated | Wolfe Research | Peer Perform |
| Dec-10-24 | Initiated | Jefferies | Hold |
| Dec-10-24 | Reiterated | Needham | Buy |
| Oct-01-24 | Downgrade | Citigroup | Buy → Neutral |
| Jun-27-24 | Initiated | Stephens | Overweight |
| Apr-03-24 | Upgrade | Citigroup | Neutral → Buy |
| Jul-14-23 | Upgrade | Needham | Hold → Buy |
| Dec-07-22 | Initiated | RBC Capital Mkts | Sector Perform |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Jul-20-22 | Downgrade | BofA Securities | Buy → Neutral |
| Jul-20-22 | Initiated | UBS | Neutral |
| Jul-18-22 | Downgrade | BTIG Research | Buy → Neutral |
| Apr-25-22 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Apr-04-22 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-15-21 | Downgrade | Citigroup | Buy → Neutral |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Oct-14-21 | Initiated | Redburn | Neutral |
| Jul-06-21 | Upgrade | Evercore ISI | In-line → Outperform |
| Nov-20-20 | Downgrade | Needham | Buy → Hold |
| Nov-05-20 | Reiterated | Needham | Buy |
| Jun-30-20 | Upgrade | Cowen | Market Perform → Outperform |
| Jun-03-20 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Apr-30-20 | Reiterated | Needham | Buy |
| Apr-30-20 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Apr-07-20 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-27-20 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| Jan-13-20 | Reiterated | Needham | Buy |
| Jan-08-20 | Initiated | Wells Fargo | Equal Weight |
| Jan-07-20 | Initiated | Citigroup | Buy |
| Jan-02-20 | Downgrade | Evercore ISI | Outperform → In-line |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Aug-01-19 | Reiterated | Needham | Buy |
| May-02-19 | Reiterated | Needham | Buy |
| Jan-31-19 | Reiterated | Needham | Buy |
| Jan-02-19 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Oct-09-18 | Initiated | UBS | Neutral |
| Sep-13-18 | Downgrade | BofA/Merrill | Buy → Neutral |
View All
Hologic Inc Stock (HOLX) Latest News
Hologic's GYN Surgical Segment Looks Poised for Long-Term Growth - Yahoo Finance
Spotting Winners: Hologic (NASDAQ:HOLX) And Medical Devices & SuppliesImaging, Diagnostics Stocks In Q3 - TradingView — Track All Markets
Hologic stock (HOLX) after-hours on Dec. 24, 2025: CVR milestone risk, Blackstone–TPG deal spread, and what to watch before the next market open - ts2.tech
Hologic says 2026 CVR is more challenging with stopped shipment of product (HOLX:NASDAQ) - Seeking Alpha
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Diamond Hill Investment Group, Inc. (Nasdaq – DHIL), Synchronoss Technologies (Nasdaq – SNCR), Forge Global Holdings, Inc. (NYSE – FRGE), Hologic, Inc. (Nasdaq – HOLX) - GlobeNewswire Inc.
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock - Yahoo Finance
HOLX vs. LH: Which MedTech Stock Is the Stronger Investment Now? - Yahoo Finance
Is Hologic Inc. stock affected by interest rate hikesWeekly Trade Summary & Long-Term Safe Investment Ideas - Улправда
Hologic, Inc. (HOLX) is attracting investor attention: Here is what you should know - MSN
Why retail investors favor Hologic Inc. stockJuly 2025 Levels & Real-Time Market Sentiment Alerts - Улправда
How sustainable is Hologic Inc. stock dividend payoutEarnings Trend Report & Weekly High Potential Alerts - Улправда
Will Hologic Inc. (HO1) stock sustain uptrend momentumQuarterly Growth Report & Verified Short-Term Plans - Улправда
Is Hologic Inc. stock positioned for digital transformation2025 Fundamental Recap & Low Drawdown Momentum Ideas - Улправда
Can Hologic Inc. stock maintain operating margins2025 Market WrapUp & AI Optimized Trading Strategy Guides - Улправда
Meeting tomorrow's diagnostic demands in today's lab - SelectScience
Why Hologic Inc. stock is recommended by analystsJuly 2025 Closing Moves & Consistent Return Investment Signals - DonanımHaber
Why Hologic Inc. stock is seen as undervaluedMarket Trend Review & Consistent Profit Alerts - DonanımHaber
Will Hologic Inc. stock reach Wall Street targetsEarnings Risk Report & Weekly High Conviction Trade Ideas - DonanımHaber
Can Hologic Inc. stock deliver surprise earnings beat2025 Volume Leaders & Real-Time Volume Surge Alerts - Улправда
Digital Breast Tomosynthesis Equipment Market Set to Boom | - openPR.com
Is Hologic Inc. stock gaining market shareJuly 2025 Big Picture & AI Powered Market Trend Analysis - ulpravda.ru
Market Outlook: Will Hologic Inc. (HO1) stock sustain uptrend momentumMarket Growth Summary & Free Accurate Trade Setup Notifications - moha.gov.vn
Hologic data highlights AI’s role in improving mammography accuracy - DOTmed
Portfolio Shifts: Can Hologic Inc. stock maintain operating marginsTrade Entry Report & Fast Exit and Entry Trade Guides - Улправда
Hologic (HOLX) shareholders have earned a 4.8% return over the last year - Yahoo Finance
Responsive Playbooks and the HOLX Inflection - news.stocktradersdaily.com
Hologic's Genius AI Detection Shows Value by Spotting Missed Cancers - sharewise.com
Hologic (HOLX) insider reports 90 shares withheld for tax obligations - Stock Titan
HOLX's Genius AI Mammography Flags Missed Breast Cancer Cases - Yahoo Finance
Why Hologic (HOLX) is a Top Momentum Stock for the Long-Term - Yahoo Finance
Bacterial Drug Sensitivity Testing Market Future Outlook - openPR.com
Uterine Fibroid Treatment Market Forecast to 2032 Reveals Key - openPR.com
Virtual Biopsy Market Emerging Player Outperforming | GE Healthcare, Hologic, Hitachi - openPR.com
Hologic’s AI mammography tech flags previously missed breast cancers - Investing.com India
Study: AI-Powered Mammography Technology Helps Flag Breast Cancer Cases Initially Interpreted as Negative - Imaging Technology News
Hologic’s AI mammography tech flags previously missed breast cancers By Investing.com - Investing.com Nigeria
Hologic Says AI Mammography Flagged 32% of Missed Cancers in General Study - marketscreener.com
Hologic's AI-Powered Mammography Technology Flagged a Third of B - GuruFocus
Hologic’s AI-Powered Mammography Technology Flagged a Third of Breast Cancer Cases Initially Interpreted as Negative in Study of 7,500 Screening ExamsHologic, Inc. - Hologic, Inc. - Investor Relations
Hologic stock hits 52-week high at $75.14 By Investing.com - Investing.com Canada
Hologic stock hits 52-week high at $75.14 - Investing.com
Hologic's BCI test shows growing impact in endocrine therapy decisions - MSN
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
What Is Driving Hologic's Strength in the US Diagnostics Market? - The Globe and Mail
Hologic ticks higher amid report on financing for potential takeover - MSN
Palmetto Grain Brokerage - Palmetto Grain Brokerage
Is Hologic Stock Outperforming the Nasdaq? - Barchart.com
Halper Sadeh LLC Encourages DHIL, SNCR, FRGE, HOLX Shareholders to Contact the Firm to Discuss Their Rights - The Malaysian Reserve
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of - GlobeNewswire
Edge-GPU Breast Tomosynthesis Box Market Intelligence 2025-2029 Featuring Hologic, GE Healthcare Technologies, Fujifilm, Canon Medical Systems, Philips and MoreResearchAndMarkets.com - The AI Journal
Marshall Wace LLP Purchases Shares of 317,277 Hologic, Inc. $HOLX - MarketBeat
Hologic Inc Stock (HOLX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.06%
0.85%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):